BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19055119)

  • 21. Small cell cancer of the bladder: pathology, diagnosis, treatment and prognosis.
    Ismaili N; Arifi S; Flechon A; El Mesbahi O; Blay JY; Droz JP; Errihani H
    Bull Cancer; 2009 Jun; 96(6):E30-44. PubMed ID: 19457759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New advances in the second-line treatment of small cell lung cancer.
    Hurwitz JL; McCoy F; Scullin P; Fennell DA
    Oncologist; 2009 Oct; 14(10):986-94. PubMed ID: 19819917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of small cell lung cancer in the elderly.
    Jeremic B; Zimmermann FB; Bamberg M; Molls M
    Hematol Oncol Clin North Am; 2004 Apr; 18(2):433-43. PubMed ID: 15094180
    [No Abstract]   [Full Text] [Related]  

  • 24. [Commentary to the diagnostic and therapeutic recommendations of Polish Lung Cancer Group (see page 88)].
    Roszkowski-Sliz K
    Pneumonol Alergol Pol; 2007; 75(1):1. PubMed ID: 17541905
    [No Abstract]   [Full Text] [Related]  

  • 25. Novel approaches for the treatment of small cell lung cancer.
    Wakelee H; Kelly K
    Hematol Oncol Clin North Am; 2004 Apr; 18(2):499-518. PubMed ID: 15094184
    [No Abstract]   [Full Text] [Related]  

  • 26. [Guideline for chemotherapy of malignant lung cancer].
    Yamamoto N; Fukuoka M
    Gan To Kagaku Ryoho; 2002 Jun; 29(6):985-1007. PubMed ID: 12109452
    [No Abstract]   [Full Text] [Related]  

  • 27. Cognitive dysfunction in patients with small-cell lung cancer: incidence, causes, and suggestions on management.
    Kanard A; Frytak S; Jatoi A
    J Support Oncol; 2004; 2(2):127-32; discussion 133-5, 138-40. PubMed ID: 15328816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug therapy for small-cell lung cancer (SCLC)--new molecular strategies for therapy].
    Brückl WM; Lampert S; Zirlik S; Hahn EG; Wiest GH
    Pneumologie; 2008 Jan; 62(1):23-30. PubMed ID: 17948174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicity of small cell lung cancer treatment.
    Casas F; Viñolas N
    Hematol Oncol Clin North Am; 2004 Apr; 18(2):461-81. PubMed ID: 15094182
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical trials referral resource. Extensive-stage small-cell lung cancer.
    Cheson BD; Feigal EG; Phillips PH
    Oncology (Williston Park); 1993 Nov; 7(11):60, 63-4. PubMed ID: 8280578
    [No Abstract]   [Full Text] [Related]  

  • 31. Small cell lung cancer at Earl K. Long Memorial Hospital.
    Prados M
    J La State Med Soc; 1982; 134(3):73-8. PubMed ID: 6288817
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment of non small cell lung cancer].
    Skricková J; Coupek P; Babicková L; Tomísková M; Kaplanová J; Princ D; Kadlec B; Spelda S
    Klin Onkol; 2008; 21(6):317-29. PubMed ID: 19382595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specifically targeted gene therapy for small-cell lung cancer.
    Christensen CL; Zandi R; Gjetting T; Cramer F; Poulsen HS
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):437-52. PubMed ID: 19374598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intensive chemotherapy with bone marrow autograft in solid tumors].
    Sculier JP; Stryckmans P; Klastersky J
    Rev Med Brux; 1983 Jun; 4(6):409-15. PubMed ID: 6308742
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical and experimental studies on lung cancer].
    Wu SF
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1984 Feb; 7(1):47-50. PubMed ID: 6088190
    [No Abstract]   [Full Text] [Related]  

  • 36. NCCN Small-Cell Lung Cancer Practice Guidelines. The National Comprehensive Cancer Network.
    Demetri G; Elias A; Gershenson D; Fossella F; Grecula J; Mittal B; Raschko J; Robertson J
    Oncology (Williston Park); 1996 Nov; 10(11 Suppl):179-94. PubMed ID: 8953602
    [No Abstract]   [Full Text] [Related]  

  • 37. Guidelines update: non-small cell lung cancer.
    National Comprehensive Cancer Network
    J Natl Compr Canc Netw; 2005 Mar; 3(2):xxix-xxx. PubMed ID: 19817021
    [No Abstract]   [Full Text] [Related]  

  • 38. [Second-line treatment and targeted therapy of advanced lung cancer].
    Nakamura Y; Yamamoto N
    Gan To Kagaku Ryoho; 2009 May; 36(5):710-6. PubMed ID: 19461168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of intensified chemotherapy with hematopoietic progenitors in small-cell lung cancer: A meta-analysis of the published literature.
    Jiang J; Shi HZ; Deng JM; Liang QL; Qin SM; Wu C
    Lung Cancer; 2009 Aug; 65(2):214-8. PubMed ID: 19118919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma.
    Budak-Alpdogan T; Chen B; Warrier A; Medina DJ; Moore D; Bertino JR
    Clin Cancer Res; 2009 Feb; 15(4):1232-40. PubMed ID: 19174488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.